666752-18-7 Usage
Uses
Used in Organic Synthesis:
(5-bromo-3-methyl-1H-indol-2-yl)methanol is used as a building block in organic synthesis for the creation of new compounds with specific pharmacological and chemical properties. The presence of the bromine and methyl groups in its structure makes it a potentially valuable component for synthesizing a variety of molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (5-bromo-3-methyl-1H-indol-2-yl)methanol is utilized as a key intermediate in the development of new drugs. Its unique structure and functional groups contribute to the design and synthesis of novel therapeutic agents.
Used in Agrochemical Development:
(5-bromo-3-methyl-1H-indol-2-yl)methanol is also employed in the agrochemical sector for the development of new compounds with applications in agriculture, such as pesticides or plant growth regulators. Its structural features allow for the creation of molecules with targeted biological activities.
Check Digit Verification of cas no
The CAS Registry Mumber 666752-18-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,6,6,7,5 and 2 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 666752-18:
(8*6)+(7*6)+(6*6)+(5*7)+(4*5)+(3*2)+(2*1)+(1*8)=197
197 % 10 = 7
So 666752-18-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H10BrNO/c1-6-8-4-7(11)2-3-9(8)12-10(6)5-13/h2-4,12-13H,5H2,1H3
666752-18-7Relevant academic research and scientific papers
Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
-
Page/Page column 21-22, (2008/06/13)
Novel compounds useful as chemotherapeutic and chemopreventive agents are provided. The compounds are analogs of indole-3-carbinol metabolites wherein the structures and substituents of the compounds are selected to enhance the compounds' overall efficacy, particularly with respect to therapeutic activity, oral bioavailability, long-term safety, patient tolerability, and therapeutic window. The compounds are useful not only in treatment of cancer but also in prevention of cancer. One preferred class of the novel compounds have the structure of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, and R12 are defined herein. Pharmaceutical compositions are provided as well, as are methods of synthesis and use.
